TipRanks
BioMark Diagnostics (DE:20B)
FRANKFURT:20B
Germany Market
20B
BioMark Diagnostics
RESEARCH TOOLSreports

BioMark Diagnostics (20B) Cash flow

5 Followers

BioMark Diagnostics Cash Flow

DE:20B's free cash flow for Q4 2026 was C$504.22K. For the 2026 fiscal year, DE:20B's free cash flow was decreased by C$3.64K and operating cash flow was C$-119.69K. See a summary of the company’s cash flow.
Cash Flow
Jun 26Jun 25Jun 24Jun 22Jun 21
Operating Cash Flow
C$ -1.09MC$ -1.09MC$ -982.52KC$ -914.42KC$ -455.55K
Investing Cash Flow
C$ -396.05KC$ -3.53KC$ -4.39KC$ -5.30KC$ -3.20K
Financing Cash Flow
C$ -377.83KC$ 3.42MC$ 1.07MC$ 609.05KC$ 724.63K
End Cash Position
C$ 619.10KC$ 2.48MC$ 156.75KC$ 72.04KC$ 877.68K
Free Cash Flow
C$ -1.09MC$ -1.10MC$ -986.91KC$ -919.72KC$ -455.55K
Currency in CAD

BioMark Diagnostics Cash Flow